Feed SVYSF
SV

Solvay S.A. SVYSF · OTC

$25.05 -10.05% (-$2.80)

Summary

38 / 100 · Bulios Score

What speaks for it

  • Out of every 100 EUR of revenue, 8.0 EUR is left as free cash.
  • It has been profitable 5 years in a row.

What to watch

  • Revenue fell by 33% a year over the last 3 years.
  • It pays out more in dividends than it earns: 8,682% of profit.
  • The share price is above the Bulios Fair Price.
  • It missed profit estimates 6 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive
Bulios Fair Price
Current price $25.05
P/E today 853.9 3,341% higher
5-year average P/E 24.8
P/E today 853.9
Chemicals industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 853.9 EUR for 1 EUR of yearly profit. Over the last five years it was 24.8 EUR on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (EUR)

Diluted EPS (EUR)

  • Analyst estimate

Revenue fell by 13% a year over 5 years. Over the last 3 years it fell by 33% a year. For the next fiscal year analysts expect revenue to fall by 11%. Earnings per share fell by 75% a year over the last 3 years.

Growth in detail

Does it make money?

Reasonably

Where 100 EUR of revenue goes

Net profit, industry median (Chemicals) 4.7 EUR

Out of every 100 EUR of revenue, 0.1 EUR is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 6.1 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, at risk
Yield
10.17%
Paid out of profit
8,682%
Raised in a row
1 year

You receive $2.83 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy